Gaudium IVF & Women Health Complete Financial Statements

4 Years of Data
2025 - 2022

In FY2025, Gaudium IVF & Women Health (GAUDIUMIVF) reported revenue ₹32 Cr, net profit ₹9 Cr and EPS ₹1.53, with a net profit margin of 28.1% and ROE of 19.6%. Full financial statements from FY2022 to FY2025 (4 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Explore GAUDIUMIVF investment value to estimate fundamental worth using multiple valuation models.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 28.13% 2025 data
EBITDA Margin 43.75% 2025 data
Operating Margin 43.00% 2025 data
Return on Assets 10.11% 2025 data
Return on Equity 19.57% 2025 data

Balance Sheet Ratios

Current Ratio 13.50 2025 data
Equity Ratio 51.69% 2025 data
Asset Turnover 0.36 2025 data

GAUDIUMIVF Revenue, Net Profit & EBITDA — Year-on-Year Growth

GAUDIUMIVF YoY (Dec 2024 vs Sept 2025) — revenue +128.6%, net profit +200.0%, EBITDA +133.3%, expenses +100.0%. For live price, earnings ratios and company overview, see Gaudium IVF & Women Health share price screener.

Revenue Growth
+128.6%
Year-over-Year
Net Profit Growth
+200.0%
Year-over-Year
EBITDA Growth
+133.3%
Year-over-Year
Expense Growth
+100.0%
Year-over-Year
Assets Growth
+56.1%
Year-over-Year
Equity Growth
+39.4%
Year-over-Year
Operating Cash Flow Growth
+200.0%
Year-over-Year
Investing Cash Flow Growth
-200.0%
Year-over-Year
Financing Cash Flow Growth
+300.0%
Year-over-Year

GAUDIUMIVF Income Statement — Revenue, EBITDA & Net Profit

Gaudium IVF & Women Health revenue ₹32 Cr, EBITDA ₹14 Cr, net profit ₹9 Cr, EPS ₹1.53 (2025) — net profit margin 28.1%. Review GAUDIUMIVF P/E comparison to evaluate earnings-based valuation against sector peers.

Periods ₹ Crores
Particulars Sept 2025 Mar 2025 Jun 2025 Dec 2025 Dec 2024
Revenue 32 27 18 25 14
Expenses 18 18 13 18 9
EBITDA 14 9 5 7 6
Operating Profit Margin % 43.00% 33.00% 29.00% 27.00% 39.00%
Depreciation 1 0 1 1 1
Interest 1 0 1 1 0
Profit Before Tax 13 8 4 5 5
Tax 3 2 1 1 1
Net Profit 9 7 3 4 3
Earnings Per Share (₹) 1.53 1.07 0.51 0.59 0.55

GAUDIUMIVF Balance Sheet — Assets, Liabilities & Shareholders' Equity

GAUDIUMIVF total assets ₹89 Cr, total equity ₹46 Cr, total liabilities ₹ Cr (2025) — ROE 19.6%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022
ASSETS
Total Assets 89 57 37 18
Current Assets 54 38 18 14
Fixed Assets 18 19 18 4
Capital Work in Progress 7 0 0 0
Investments 5 0 0 0
Other Assets 58 39 18 14
LIABILITIES
Total Liabilities
Current Liabilities 4 4 4 3
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 46 33 23 9
Share Capital 31 1 1 1
Reserves & Surplus 16 32 22 8

GAUDIUMIVF Cash Flow Statement — Operating, Investing & Financing

Gaudium IVF & Women Health operating cash flow ₹9 Cr, investing ₹-15 Cr, financing ₹2 Cr, net cash flow ₹-5 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022
Operating Activities 9 3 24 -1
Investing Activities -15 -5 -16 -1
Financing Activities 2 -1 5 3
Net Cash Flow -5 -3 14 0